SCHEMBL984194

SCHEMBL984194

O=Cc1ccc(C=O)c2cc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
LMNA P02545 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 2/20 0.50
THRB P10828 1/20 0.50
BLM P54132 1/20 0.50
ERN1 O75460 1/20 0.42
ALDH1A1 P00352 4/20 0.41
TSHR P16473 1/20 0.41
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
GAA P10253 2/20 0.41
CYP2A6 P11509 5/20 0.39
IMPDH2 P12268 1/20 0.39
NQO2 P16083 1/20 0.39
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NQO1 P15559 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5749096 0.88 ALDH1A1 (0.43) KMT2ALMNATDP1MEN1THRB
SCHEMBL29392367 0.84 ALDH1A1 (0.50) KMT2ALMNATDP1MEN1THRB
SCHEMBL39718 0.84 ALDH1A1 (0.50) KMT2ALMNATDP1MEN1THRB
SCHEMBL13173721 0.83 NR4A1 (0.47) KMT2ALMNATDP1MEN1ALDH1A1
SCHEMBL31340003 0.82 ALDH1A1 (0.49) KMT2ALMNATDP1MEN1THRB
SCHEMBL30446471 0.82 ALDH1A1 (0.49) KMT2ALMNATDP1MEN1THRB
SCHEMBL548710 0.82 ALDH1A1 (0.49) KMT2ALMNATDP1MEN1THRB
SCHEMBL548781 0.82 ALDH1A1 (0.49) KMT2ALMNATDP1MEN1THRB
SCHEMBL11268929 0.82 ALDH1A1 (0.49) KMT2ALMNATDP1MEN1ERN1
SCHEMBL652955 0.81 LMNA (0.58) KMT2ALMNATDP1MEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US claimed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US claimed
EP-2250151-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES Merck Patent GmbH (DE) 2010-11-17 EP claimed
WO-2009112854-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH (DE) 2009-09-17 WO claimed
CN-111116528-B Method for producing aromatic primary diamine 罗地亚经营管理公司 2023-08-01 CN disclosed
US-11066377-B2 Process for producing aromatic primary diamines RHODIA OPERATIONS (FR) 2021-07-20 US disclosed
US-10899726-B2 Process for producing aromatic primary diamines RHODIA OPERATIONS (FR) 2021-01-26 US disclosed
EP-3674285-A1 PROCESS FOR PRODUCING M-XYLYLENEDIAMINE RHODIA OPERATIONS (FR) 2020-07-01 EP disclosed
US-20200172501-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES SPECIALTY OPERATIONS FRANCE (FR) 2020-06-04 US disclosed
CN-111116528-A Process for producing aromatic primary diamines 罗地亚经营管理公司 2020-05-08 CN disclosed
EP-3166921-B1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES RHODIA OPERATIONS (FR) 2020-02-19 EP disclosed
CN-106488905-B Process for producing aromatic primary diamines 罗地亚经营管理公司 2019-12-17 CN disclosed
US-20170217916-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES SPECIALTY OPERATIONS FRANCE (FR) 2017-08-03 US disclosed
EP-3166921-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES Rhodia Operations (FR) 2017-05-17 EP disclosed
WO-2016004867-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES RHODIA OPERATIONS (FR) 2016-01-14 WO disclosed
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US disclosed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US disclosed
EP-2250151-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES Merck Patent GmbH (DE) 2010-11-17 EP disclosed
WO-2009112854-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH (DE) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES NR2E3, NR4A2, NR4A3 KMT2A 1734/4885LMNA 2067/4885TDP1 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.